Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Liver Cancer Research

<< Previous

Bullboard Posts

Next >>

Comment by tamarindo1on Feb 05, 2021 6:26pm

169 Views

Post# 32490845

RE:Liver Cancer Research

Ruthenium as used in the chemical industry and as a synthesis in various organic chemicals in the pharmaceutical industry, in addition its replacement of mercury in various membrane technologies is creating a growing demand for this extremely rare metal compound causing a high CAGR.

I did not know this.

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023